Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study

C. Haifer, A. Srinivasan, S. Menon, Y. An, S. Picardo, D. Van Langenberg, J. Begun, S. Ghaly, L. Thin

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)155-156
Number of pages2
JournalJournal of Gastroenterology and Hepatology
Publication statusPublished - Sep 2019

Cite this